PUBLICATIONS

OPRI has been leading the paradigm shift in real world evidence for the past 12 years, by delivering pragmatic clinical trials, disease registries and database research.
OPRI’s founder, Professor David Price, has been a pioneer in setting new quality standards for database research which are fully adhered to by the research institute.

2020 Publications

Extra-fine beclometasone dipropionate/formoterol fumarate vs double bronchodilation therapy in patients with COPD: a historical real-world non-inferiority study - International Journal of Chronic Obstructive Pulmonary Disease

Advancing the Patient EXperience (APEX) in COPD registry: Study design and strengths - Journal of the American Board of Family Medicine

A multinational observational study exposing the burden and impact of self-reported concomitant rhinitis and identifying primary care patients at risk of asthma exacerbations - Journal of Asthma and Allergy

Blood Eosinophil Count Predicts Treatment Failure and Hospital Readmission for COPD - ERJ Open Research

The Long-Term Burden of COPD Exacerbations during Maintenance Therapy and Lung Function Decline - International Journal of Chronic Obstructive Pulmonary Disease

Development of the Advancing the Patient EXperience (APEX) in COPD registry: a modified Delphi Study - Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation

International severe asthma registry (ISAR): protocol for a global registry - BMC Medical Research Methodology

Association between COPD exacerbations and lung function decline during maintenance therapy - Thorax

Adequacy of therapy for people with both COPD and heart failure in the UK: historical cohort study - Pragmatic and Observational Research

Opportunities to diagnose fibrotic lung diseases in routine care: a primary care cohort study - Respirology

Historical database cohort study addressing the clinical patterns prior to idiopathic pulmonary fibrosis (IPF) diagnosis in UK primary care - BMJ Open

Comparative safety profile of the fixed-dose combination corticosteroid and long-acting β2-agonist fluticasone propionate/formoterol fumarate: a 36-month longitudinal cohort study in UK primary care - Drugs

2019 Publications

Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry - CHEST

International Severe Asthma Registry: Mission Statement - CHEST

A multinational observational study identifying primary care patients at risk of overestimation of asthma control - NPJ Primary Care Respiratory Medicine

Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study - NPJ Primary Care Respiratory Medicine

Management of community-acquired pneumonia: an observational study in UK primary care - Pragmatic and Observational Research

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD - ERJ Open Research

AAAAI 2020 Annual Meeting

Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis
Evaluating the Real-life Effect of MP-AzeFlu On Asthma Control In Patients With Allergic Rhinitis and Asthma In UK Primary Care

REG 2020

Cluster analysis according to biomarker profile differentiates clinical subgroups in the International Severe Asthma Registry (ISAR)

The Demographic and Clinical Characteristics of Eosinophilic and non-Eosinophilic Phenotypes of Severe Asthma in International Severe Asthma Registry (ISAR)
Demographic and Clinical Characteristics of Patients with Severe Asthma who Continued, Stopped or Switched Biologic Therapy

COPD Primary Care: Providing a Clinically Relevant Picture for Clinicians

ATS 2020

The Impact of Exacerbation Burden on Lung Function Trajectory in a Broad UK Asthma Population: A Large Longitudinal Cohort Study

Global Access for Biologics in the Treatment of Severe Asthma: A Challenge to Personalized Medicine

Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR)

A Global Survey of Blood Eosinophil Distribution in Severe Asthma Patients: Data from the International Severe Asthma Registry (ISAR)

Characterization of Eosinophilic and Non-Eosinophilic Severe Asthma Phenotypes and Proportion of Patients with These Phenotypes in the International Severe Asthma Registry (ISAR)

Biomarker Relatability in the International Severe Asthma Registry

Disease Burden for Patients with Chronic Obstructive Pulmonary Disease Receiving Maintenance Therapy

previous arrow
next arrow
Full screenExit full screen
Slider